CORE LABORATORIES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.07 USD | +3.27% |
|
+0.47% | -3.34% |
| Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
| Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 EPS $0.19, vs. Street Est of $0.16 | MT |
Financials (USD)
| Sales 2024 * | 527M | Sales 2025 * | 574M | Capitalization | 775M |
|---|---|---|---|---|---|
| Net income 2024 * | 38M | Net income 2025 * | 51M | EV / Sales 2024 * | 1.72 x |
| Net Debt 2024 * | 132M | Net Debt 2025 * | 79M | EV / Sales 2025 * | 1.49 x |
| P/E ratio 2024 * |
20.5
x | P/E ratio 2025 * |
15.2
x | Employees | 3,600 |
| Yield 2024 * |
0.24% | Yield 2025 * |
0.24% | Free-Float | 98.97% |
More Fundamentals
* Assessed data
More news
Latest transcript on Core Laboratories Inc.
More recommendations
More press releases
| 1 day | -2.71% | ||
| 1 week | -0.96% | ||
| Current month | -3.22% | ||
| 1 month | -0.66% | ||
| 3 months | +1.66% | ||
| 6 months | -28.66% | ||
| Current year | -6.40% |
1 week
16.52
17.29
1 month
16.4118.22
Current year
13.8218.22
1 year
13.8227.95
3 years
13.1949.87
5 years
6.6866.65
10 years
6.68194.04
| Managers | Title | Age | Since |
|---|---|---|---|
Lawrence Bruno
CEO | Chief Executive Officer | 64 | - |
Christopher Hill
DFI | Director of Finance/CFO | 54 | - |
| Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Curtis Anastasio
BRD | Director/Board Member | 67 | 23-06-27 |
| Director/Board Member | 71 | 19-12-31 | |
| Director/Board Member | 74 | 15-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 17.07 | +3.27% | 693 893 |
| 24-04-24 | 16.53 | -2.71% | 412,749 |
| 24-04-23 | 16.99 | +0.12% | 425,546 |
| 24-04-22 | 16.97 | -1.22% | 307,758 |
| 24-04-19 | 17.18 | +1.12% | 365,199 |
Delayed Quote Nyse, April 24, 2024 at 04:00 pm EDT
More quotes
Core Laboratories Inc. is a provider of proprietary and patented reservoir description and production enhancement services and products for the oil and gas industry. The Company helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. It makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The Company has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The Company has approximately 70 offices in more than 50 countries.
Sector
Business Support Services
Calendar
08:30am
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
16.53
USD
Average target price
19.22
USD
Spread / Average Target
+16.29%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.40% | 775M | |
| +12.71% | 16.53B | |
| 0.00% | 6.79B | |
| -11.83% | 2.89B | |
| -13.46% | 2.65B | |
| -33.87% | 1.67B | |
| +3.80% | 1.24B | |
| -10.58% | 1.02B | |
| -7.74% | 860M | |
| -10.16% | 800M |
- Stock Market
- Equities
- CLB Stock
